Richard T. LeBuhn, Director at Asterias Biotherapeutics, Inc. (AST), bought 5,000 shares at $2.38 ($12K) on 2016-06-29, disclosed to the SEC on 2016-07-01.
Open-market purchase of $12k AST by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CMRO | BUY | 2013-02-22 | $10K | — | Filing → |